Please assess the completion status of the following clinical trial:

Trial Title: Fluid Overload Management and Vascular Stiffness in Chronic Kidney Disease Patients With Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult (\>18 years old) outpatient with uncontrolled hypertension; defined as, AMBP ≥ 130/80 mmHg despite treatment~* With an estimated glomerular filtration rate (eGFR) of 15-45 ml/min/1.73 m2.~* Fluid overload of more than 5% of estimated normal ECFV, as assessed by Bio-impedance spectroscopy (we are using the Body Composition Monitor, a validated device marketed by Fresenius, Canada).~Exclusion Criteria:~* Pregnancy or lactation~* Declined informed consent~* Patients with cognitive dysfunction~* Surgery within six weeks of the study~* Patients with heart failure, atrial fibrillation, stroke, nephrotic syndrome and active auto-immune disease~* Patients with severe life-limiting comorbidities like cancer~* Patients with amputated limbs (despite the fact that the BCM device can be used if people have a unilateral amputation, the home devices measure via 2 legs).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention group (Type: EXPERIMENTAL): Bio-impedance spectroscopy.~Treatment algorithm for diuretic therapy.
- Control group (Type: NO_INTERVENTION): No intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).